Qu’apportent les nouvelles recommandations sur le diagnostic et le traitement de la sarcoïdose ?

[1]  A. Chee,et al.  Effect of Needle Size on Diagnosis of Sarcoidosis with Endobronchial Ultrasound-guided Transbronchial Needle Aspiration: Systematic Review and Meta-Analysis. , 2021, Annals of the American Thoracic Society.

[2]  E. Crouser,et al.  Challenges of Sarcoidosis and Its Management. , 2021, The New England journal of medicine.

[3]  P. Sève,et al.  Challenging Mimickers in the Diagnosis of Sarcoidosis: A Case Study , 2021, Diagnostics.

[4]  Alexander G. Mathioudakis,et al.  ERS clinical practice guidelines on treatment of sarcoidosis , 2021, European Respiratory Journal.

[5]  L. Boussel,et al.  Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis , 2021, Cells.

[6]  G. Bernard,et al.  Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis , 2020, Chest.

[7]  A. Wells,et al.  BTS Clinical Statement on pulmonary sarcoidosis , 2020, Thorax.

[8]  Justine R. Smith,et al.  Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis , 2020, British Journal of Ophthalmology.

[9]  R. Blankstein,et al.  Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline , 2020, American journal of respiratory and critical care medicine.

[10]  S. Birring,et al.  Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis , 2020, European Respiratory Review.

[11]  J. Grutters,et al.  In Which Patients with Sarcoidosis Is FDG PET/CT Indicated? , 2020, Journal of clinical medicine.

[12]  W. Piotrowski,et al.  Diagnosis of sarcoidosis - the updated ATS 2020 recommendations through the prism of everyday clinical practice. , 2020, Advances in respiratory medicine.

[13]  S. Walsh,et al.  Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. , 2019, The New England journal of medicine.

[14]  Alexis Tumolo,et al.  Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function , 2019, Journal of cardiovascular electrophysiology.

[15]  C. Chiquet,et al.  Expert opinion on the use of biological therapy in non-infectious uveitis , 2019, Expert opinion on biological therapy.

[16]  Justine R. Smith,et al.  Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis , 2019, British Journal of Ophthalmology.

[17]  D. Clifford,et al.  Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group , 2018, JAMA neurology.

[18]  I. Annesi-Maesano,et al.  Clinical phenotypes of extra-pulmonary sarcoidosis. The EpiSarc study , 2018, Sarcoidosis and other granulomatous ILD/DPLD.

[19]  M. Gold,et al.  2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. , 2018, Journal of the American College of Cardiology.

[20]  Tracey A. Cho,et al.  Infliximab for the treatment of CNS sarcoidosis , 2017, Neurology.

[21]  F. Terasaki,et al.  New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan , 2017 .

[22]  A. Wells,et al.  Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. , 2017, JACC. Cardiovascular imaging.

[23]  D. Galanaud,et al.  Long-term outcomes of refractory neurosarcoidosis treated with infliximab , 2017, Journal of Neurology.

[24]  R. Borie,et al.  Treatment of neurosarcoidosis , 2016, Neurology.

[25]  Amit R. Patel,et al.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.

[26]  M. Soussan,et al.  Clinical Presentation of Sarcoidosis and Diagnostic Work-Up , 2014, Seminars in Respiratory and Critical Care Medicine.

[27]  H. Algood,et al.  Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study. , 2013, JAMA dermatology.

[28]  R. Baughman,et al.  Established and experimental medical therapy of pulmonary sarcoidosis , 2013, European Respiratory Journal.

[29]  L. Kodjikian,et al.  Ocular sarcoidosis: when should labial salivary gland biopsy be performed? , 2013, Graefe's Archive for Clinical and Experimental Ophthalmology.

[30]  P. le Hoang,et al.  Minor salivary gland biopsy in diagnosing ocular sarcoidosis , 2011, British Journal of Ophthalmology.

[31]  S. Lubitz,et al.  Primary Prevention of Sudden Cardiac Death in Silent Cardiac Sarcoidosis: Role of Programmed Ventricular Stimulation , 2011, Circulation. Arrhythmia and electrophysiology.

[32]  M. Rovaris,et al.  Central nervous system sarcoidosis--diagnosis and management. , 1999, QJM : monthly journal of the Association of Physicians.

[33]  Statement on Sarcoidosis , 1999 .

[34]  Y. Comhaire-Poutchinian,et al.  [Ocular sarcoidosis]. , 1989, Bulletin de la Societe belge d'ophtalmologie.